PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
about
Immunogenicity and immunomodulatory effects of the human chondrocytes, hChonJ.Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allograftsIFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cellsAntitumor activity of nivolumab on hemodialysis after renal allograft rejection.Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.Adenovirus-Mediated CCR7 and BTLA Overexpression Enhances Immune Tolerance and Migration in Immature Dendritic Cells.Inhibitory receptors on lymphocytes: insights from infectionsPembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients.Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation.Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma.
P2860
Q33706923-2FCE5E90-318F-4E17-99AF-59050C550B8DQ34193534-478B717B-904A-4CDF-B910-94E1A4D67941Q34549740-111EBD1E-F2A6-4A68-80AF-A773974538C0Q35638639-1C2E5269-4E26-475D-BC7C-8FE818157CDFQ37346073-7FCC7CC7-2B25-4AF4-B51E-B32B84EA7CFDQ37585824-CC927296-8D3A-4DEC-A203-B4D3D0A8A64FQ37723724-2C863DD0-17F0-4D02-8B40-799EB0C77205Q37996395-D16A0CB3-AE8D-434A-BBFA-D1879B9708C3Q42315438-269E9ED1-B553-46D2-B3EE-9992FAAF0C9EQ47094450-6C34ACAE-92BD-47B6-B3B2-9BD9FDF6AA90Q51218209-CF5CB02E-03AA-4317-ADFA-37EA6D704C79Q52593728-B59B3289-6ABA-4AD0-BE2A-4DFB817E60C4Q55417521-68977F21-5AB8-491C-852A-493C740AC213
P2860
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
@en
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
@nl
type
label
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
@en
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
@nl
prefLabel
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
@en
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation.
@nl
P2093
P2860
P1476
PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation
@en
P2093
Carrie Gibbons
Jiong Tian
Leo Buhler
Maria-Luisa del Rio
P2860
P304
P356
10.1111/J.1432-2277.2008.00726.X
P577
2008-07-25T00:00:00Z